Ariad’s Iclusig Cleared For European Approval By CHMP
This article was originally published in The Pink Sheet Daily
Executive Summary
Europe's top scientific advisory panel, CHMP, granted positive opinions for Ariad's new leukemia therapy Iclusig, Gilead's four-drug HIV therapy, Stribild and Baxter's subcutaneous IgG formulation, HyQvia, at its March 2013 meeting,